Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.

Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. PLoS One. 2015; 10(10):e0139049.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Biomarkers, Tumor
CA-19-9 Antigen
Female
Humans
Male
Middle Aged
Pancreatic Neoplasms
Pancreatitis, Chronic
Sensitivity and Specificity

authors with profiles

Karen Kaul